For the two remaining genes, NLGN4Y (ENSP00000342535) and TBR1 (ENSP00000374205), in 2019, researchers from University of Southampton summarized NLGN4Y as a multi-omics level driver for lung cancer at least at epigenomics and transcriptomics levels (Jeyananthan and Niranjan, 2019). Here, NLGN4Y is linked to lung carcinoma.